It is reported that the serum autoantibodies against GAGE7, MAGEA1, PGP9.5, CAGE and p53 could be used for lung cancer diagnosis, while autoantibodies to PGP9.5 particularly correlate with poor prognosis for lung cancer patients (135). Here, UCHL1 is linked to lung carcinoma.